Multiple Myeloma

Videos

Dr Fonseca Highlights Phase 2 GRIFFIN Study Results for Newly Diagnosed MM

12/13/2021

Rafael Fonseca, MD, Mayo Clinic, discusses new results from the Phase 2 GRIFFIN study of daratumumab, as part of a quadruplet regimen in newly diagnosed multiple myeloma, presented at the 2021 ASH Annual Meeting.

Rafael Fonseca, MD, Mayo Clinic,...

12/13/2021

Oncology

Conference Coverage

Safety and Tolerability Analysis of Melflufen plus Dexamethasone in Patients with Relapsed/Refractory MM

12/01/2021

Melfulen plus dexamethasone shows consistent safety and tolerability when compared to pomalidomide and dexamethasone.

Melfulen plus dexamethasone...

12/01/2021

Oncology

Conference Insider

Combination Daratumumab and Dexamethasone Shows Promising Efficacy in Patients with RRMM and Severe Renal Impairment

12/01/2021

Daratumumab, in combination with dexamethasone, demonstrated promising efficacy with manageable safety in patients with RRMM and severe renal impairment or on dialysis.

Daratumumab, in combination with...

12/01/2021

Oncology

Conference Coverage

Ixazomib and Daratumumab Demonstrate Tolerable Safety for Elderly Patients with Relapsed/Refractory MM

12/01/2021

When given to elderly and frail patients with relapsed/refractory MM, combination ixazomib and daratumumab, without dexamethasone, showed favorable safety.

When given to elderly and frail...

12/01/2021

Oncology

Conference Coverage

Ruxolitinib with Steroids Shows Promise in Patients with Relapsed/Refractory MM

11/30/2021

Ruxolitinib in combination with steroids is a promising treatment option for heavily pretreated patients with relapsed/refractory MM.

Ruxolitinib in combination with...

11/30/2021

Oncology

Videos

Surbhi Sidana, MD, Discusses MGTA-145 Plus Plerixafor for Same-Day HSC Mobilization in MM

07/09/2021

Surbhi Sidana, MD, discusses a phase 2 study of MGTA-145 plus plerixafor for same-day HSC mobilization for autologous transplant in patients with MM. These data were presented at the 2021 ASCO Annual Meeting.

Surbhi Sidana, MD, discusses a...

07/09/2021

Oncology

Videos

Amrita Krishnan, MD, FACP, Talks Teclistamab for Patients With MM

06/09/2021

Dr Krishnan shares findings from a phase 3 trial of teclistamab therapy for relapsed/refractory MM. These data were presented at the 2021 ASCO Annual Meeting.

Dr Krishnan shares findings from...

06/09/2021

Oncology

Videos

BCMA-Directed CAR-T Therapy Yields Durable Responses in Heavily Pretreated R/R MM

06/08/2021

Saad Usmani, MD, shares findings from the CARTITUDE-1 study of ciltacabtagene autoleucel therapy for patients with R/R MM. These data are being presented at the 2021 ASCO Annual Meeting.

Saad Usmani, MD, shares findings...

06/08/2021

Oncology

$Ajai Chari, MD, Talks Talquetamab for Relapsed/Refractory MM$

Videos

Ajai Chari, MD, Talks Talquetamab for Relapsed/Refractory MM

12/05/2020

In this video, Dr Chari discusses the findings of a phase 1 trial examining the use of talquetamab in heavily pretreated patients with relapsed/refractory MM.

In this video, Dr Chari...

12/05/2020

Oncology